Literature DB >> 8461570

Bisphosphonates in osteoporosis?

O L Bijvoet1, R Valkema, C W Löwik, S E Papapoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461570     DOI： 10.1007/bf01621915

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  27 in total

1.  Prevention of postmenopausal bone loss by tiludronate.

Authors:  J Y Reginster; M P Lecart; R Deroisy; N Sarlet; D Denis; D Ethgen; J Collette; P Franchimont
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

Review 2.  Effects of clodronate on immobilization bone loss.

Authors:  P Minaire; J Depassio; E Berard; P J Meunier; C Edouard; G Pilonchery; G Goedert
Journal:  Bone       Date:  1987       Impact factor: 4.398

3.  Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).

Authors:  W B Frijlink; O L Bijvoet; J te Velde; G Heynen
Journal:  Lancet       Date:  1979-04-14       Impact factor: 79.321

4.  Prevention of glucocorticoid-induced osteoporosis.

Authors:  I R Reid; B A Schooler; A W Stewart
Journal:  J Bone Miner Res       Date:  1990-06       Impact factor: 6.741

5.  Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  P H Reitsma; O L Bijvoet; M Potokar; L J van der Wee-Pals; M M van Wijk-van Lennep
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

6.  Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.

Authors:  H I Harinck; O L Bijvoet; A S Plantingh; J J Body; J W Elte; H P Sleeboom; J Wildiers; J P Neijt
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

7.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Authors:  P M Boonekamp; L J van der Wee-Pals; M M van Wijk-van Lennep; C W Thesing; O L Bijvoet
Journal:  Bone Miner       Date:  1986-02

8.  Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study.

Authors:  A B Hodsman
Journal:  Bone Miner       Date:  1989-01

9.  Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.

Authors:  H I Harinck; O L Bijvoet; H J Blanksma; P J Dahlinghaus-Nienhuys
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

10.  Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  I R Reid; A R King; C J Alexander; H K Ibbertson
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.